Turmeric trial for cervical precancer pulled before it began
NCT ID NCT02554344
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial aimed to test whether curcumin (the active compound in turmeric) could safely help treat cervical precancer (CIN3). It planned to give 500 mg of curcumin twice daily for 12 weeks to women with CIN3. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- curcumin (turmeric extract)
- What this could lead to
- If it had worked, this could have pointed toward a simple, low-cost supplement to help treat cervical precancer.
- What could go wrong
- The trial was withdrawn before any participants enrolled, so we have no data on safety or effectiveness. Curcumin is poorly absorbed, and early-phase studies often fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a portable heat device match cryotherapy for cervical precancer?
- Could a Light-Activated cream replace surgery for cervical precancer?
- Cervical surgery may alter blood flow to the uterus
- Enzyme-HPV link in cervical disease explored
- Anesthesia choice may change surgical outcomes in cervical treatment
- Ice pack on the belly may ease pain after keyhole hysterectomy